Arriving in the landscape of obesity therapy, retatrutide is a unique approach. Unlike many available medications, retatrutide operates as a twin agonist, concurrently targeting both glucagon-like peptide-1 (GLP-1) and https://charliezdgk545582.blue-blogs.com/46494854/the-new-retatrutide-a-glp-gip-receptor-agonist